Conversations about cancer vaccines
Image courtesy of Pexels
Sustained and creative patient and public involvement and engagement (PPIE) is critical to the success of cancer vaccine trials and research.
The vaccine trials programme will rely on a wide range of engagement activities, with and for a variety of groups of people, to create opportunities for conversations and consultations on this fascinating and possibly game changing area of cancer research.
Preventative cancer vaccinations and minority ethnic communities
Previous PPI vaccine workshops have highlighted the need to address the issues that prevent some groups, specifically minority ethnic communities, from equal participation and trust in research. With this in mind, we organised a session to bring together community advocates with experience of cancer from British Muslim, Hindu, Sikh, Caribbean and African communities for a workshop.
New vaccines that aim to prevent cancer: Starting the conversation
OxCODE and the Centre for Personalised Medicine, together with the Oxford Cancer Cancer Vaccines PPI Panel, designed an event in June 2025 to start the conversation about vaccines for preventing cancer. The aim was to bring together academics, clinicians, members of the public, and other key stakeholders to explore the possibilities and challenges of this exciting new era for cancer research.
First steps: testing the water and preventative vaccinations
Consultations with patient groups began in the Spring and Summer of 2024. In partnership with Oxford’s Oncology Clinical Trials Office (OCTO), and with the help of professional facilitators, Oxford Cancer organised a pair of meetings to hear from people on the subject of cancer vaccinations.